Endothelin-A and -B receptors in human coronary arteries and veins

Regulatory Peptides

Volumn 63, Issue 2-3, 1996, Pages 149-156

  Opgaard, Ole Saetrum ^a   Cantera, Leonor ^a   Adner, Mikael ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Coronary artery; Coronary vein; Endothelin receptor

Indexed keywords

ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; MESSENGER RNA; N ACETYL 10,11 DIHYDRO 5H DIBENZO[A,D]CYCLOHEPTEN 5 YLGLYCYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ARTICLE; CORONARY ARTERY; CORONARY VEIN; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR DENSITY; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX;

EID: 0030570475     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-0115(96)00036-5     Document Type: Article

References (37)

1. [1] Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. and Masaki, T., A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, 332 (1988) 411-415.
2. [2] Chester, A.H., Dashwood, M.R., Clarke, J.G., Larkin, S.W., Davies, G.J., Tadjkarimi, S., Maseri, A. and Yacoub, M.H., Influence of endothelin on human coronary arteries and localization of its binding sites, Am. J. Cardiol., 63 (1989) 1395-1398.
3. [3] Saetrum Opgaard, O., Adner, M., Gulbenkian, S. and Edvinsson, L., Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins, J. Cardiovasc. Pharmacol., 23 (1994) 576-583.
4. [4] Folta, A., Joshua, I.G. and Webb, C., Dilator actions of endothelin in coronary resistance vessels and the abdominal aorta of the guinea pig, Life Sci., 45 (1989) 2627-2635.
5. [5] Wang, J., Zeballos, G.A., Kaley, G. and Hintze, T.H., Dilation and constriction of large coronary arteries in conscious dogs by endothelin, Am. J. Physiol. (Heart Circ. Physiol. 30), 261 (1991) H1379-H1386.
6. [6] Lamping, K.G., Clothier, J.L., Eastham, C.L. and Marcus, M.L., Coronary microvascular response to endothelin is dependent on vessel diameter and route of administration, Am. J. Physiol., 263 (1992) H703-H709.
7. [7] Cocks, T.M., Faulkner, N.L., Sudhir, K. and Angus, J., Reactivity of endothelin-1 on human and canine large veins compared with large arteries in vitro, Eur. J. Pharmacol., 171 (1989) 17-24.
8. [8] Stewart, D.J., Role of EDRF and endothelin in coronary vasomotor control, Basic Res. Cardiol., 86 (Suppl. 2) (1991) S77-S87.
9. [9] Arai, H., Hori, S., Aramori, I., Ohkubo, H. and Nakanishi, S., Cloning and expression of cDNA encoding an endothelin receptor, Nature, 348 (1990) 730-732.
10. [10] Sakurai, T., Yanagisawa, M., Takuwa, Y., Miyazaki, H., Kimura, S., Goto, K. and Masaki, T., Cloning of a cDNA encoding non-isopeptide-selective subtype of the endothelin receptor, Nature, 348 (1990) 732-735.
11. B receptor subtype across the menstrual cycle, J. Clin. Endocrinol. Metab., 75 (1992) 1545-1549.
12. [12] Hosoda, K., Nakao, K., Tamura, N., Arai, H., Ogawa, Y., Suga, S., Nakanishi, S. and Imura, H., Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor, J. Biol. Chem., 267 (1992) 18797-18804.
13. [13] Nakamuta, M., Takayanagi, R., Sakai, Y., Sakamoto, S., Hagisawa, H., Mizuno, T., Saito, Y., Hirose, S., Yamamoto, M. and Nawata, H., Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor, Biochem. Biophys. Res. Commun., 177 (1991) 34-39.
14. B endothelin receptor, Biochem. Biophys. Res. Commun., 178 (1991) 656-663.
15. [15] Arai, H., Nakao, K., Takaya, K., Hosoda, K., Ogawa, Y., Nakanishi, S. and Imura, H., The human endothelin-B receptor gene, J. Biol. Chem., 268 (1993) 3363-3470.
16. [16] Hori, S., Komatsu, Y., Shigemoto, R., Mizuno, N. and Nakanishi, S., Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors, Endocrinology, 130 (1992) 1885-1895.
17. B receptors in human vascular smooth muscle, J. Cardiovasc. Pharmacol., 22 (Suppl. 8) (1993) S22-S25.
18. [18] Harrison, V.J., Randriantsoa, A. and Schoeffter, P., Heterogeneity of endothelin-sarafotoxin receptors mediating contraction of pig coronary artery. Br. J. Pharmacol., 105 (1992) 511-513.
19. B receptors in canine coronary arteries, Circ. Res., 74 (1994) 105-114.
20. [20] Godfraind, T., Evidence for heterogeneity of endothelin receptor distribution in human coronary artery, Br. J. Pharmacol., 110 (1993) 1201-1205.
21. [21] Bax, W.A., Bruinvels, A.T., Van Suylen, R.J., Saxena, P.R. and Hoyer, D., Endothelin receptors in the human coronary artery, ventricle and atrium; A quantitative autoradiographic analysis, Naunyn Schmiedeberg's Arch. Pharmacol., 348 (1993) 403-410.
22. [22] Moreland, S., McMullen, D., Abboa-Offei, B. and Seymour, A., Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature, Br. J. Pharmacol., 112 (1994) 704-708.
23. B receptor, Biochem. Biophys. Res. Commun., 184 (1992) 953-959.
24. B antagonist (PD 145065) and related analogues, Med. Chem. Res., 3 (1993) 154-162.
25. A receptor antagonist, J. Pharmacol. Exp. Ther., 262 (1992) 1040-1046.
26. [26] Chomczynski, P. and Sacci, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162 (1987) 156-159.
27. [27] Högestätt, E.D., Andersson, K.-E. and Edvinsson, L., Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels, Acta Physiol. Scand., 117 (1983) 49-61.
28. [28] Furchgott, R.F. and Zawadzki, J.V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288 (1980) 373-376.
29. [29] Bove, A.A., Safford, R.E., Brum, J.M., Sufan, Q. and Dewey, J.D., Effects of thromboxane analog U46619 on endothelial damaged canine coronary arteries in vivo, Prostaglandins, 32 (1986) 665-677.
30. [30] Arunlakshana, O. and Schild, H.O., Some quantitative uses of drug antagonists, Br. J. Pharmacol., 14 (1959) 48-58.
31. 2 and receptor differentiation: a statistical analysis of competitive antagonism, Life Sci., 25 (1979) 637-654.
32. [32] Furchgott, R.F., The requirements for endothelial cells in the relaxation of arteries by acetylcholine and some other vasodilators, Trends Pharmacol. Sci., 2 (1981) 173-176.
33. [33] Cocks, T.M., Broughton, A., Dib, M., Sudhir, K. and Angus, J.A., Endothelin is blood vessel selective: studies on a variety of human and dog vessels in vitro and on regional blood flow in the conscious rabbit, Clin. Exp. Pharmacol. Physiol., 16 (1989) 243-246.
34. [34] Balligand, J.L. and Godfraind, T., Effect of nisoldipine on contractions evoked by endothelin-1 in human isolated distal and proximal coronary arteries and veins, J. Cardiovasc. Pharmacol., 24 (1994) 618-625.
35. [35] Botelho Parker, L.H., Cade, C., Phillips, P.E. and Rubanyi, G.M., Tissue specificity of endothelin synthesis and binding. In G.M. Rubanyi (Ed.), Endothelin, American Physiological Society, Oxford University Press, New York, NY, 1992, pp. 72-102.
36. [36] Bax, W.A., Aghai, Z., Van Trieht, C.L.J., Wassenaar, C. and Saxena, P.R., Different endothelin receptors involved in endothelin-1 and sarafotoxin S6b-induced contractions of the human isolated coronary artery, Br. J. Pharmacol., 113 (1994) 1471-1479.
37. A sub-type, Br. J. Pharmacol., 114 (1995) 1110-1116.